Louisiana 2023 2023 Regular Session

Louisiana House Bill HB645 Comm Sub / Analysis

                    DIGEST
The digest printed below was prepared by House Legislative Services.  It constitutes no part of the
legislative instrument.  The keyword, one-liner, abstract, and digest do not constitute part of the law
or proof or indicia of legislative intent.  [R.S. 1:13(B) and 24:177(E)]
HB 645 Reengrossed 2023 Regular Session	Dustin Miller
Abstract:  Creates the crime of unlawful production, manufacturing, distribution, or possession of
Xylazine.
Proposed law provides that it is unlawful for any person to knowingly or intentionally produce,
manufacture, distribute, or possess with intent to produce, manufacture, or distribute Xylazine.
Proposed law provides that whoever violates proposed law shall be imprisoned, with or without hard
labor, for not less than one year nor more than 10 years and, in addition, may be required to pay a
fine of not more than $15,000.
Proposed law provides that it is unlawful for any person to knowingly or intentionally possess
Xylazine.
Proposed law provides that whoever violates proposed law shall be imprisoned for not more than
six months and, in addition, may be required to pay a fine of not more than $500.
Provides that the proposed law crime of unlawful production, manufacturing, distribution, or
possession of Xylazine shall not apply to the following:
(1)The production, manufacturing, distribution, or possession of Xylazine in the course of a
legitimate veterinary practice.
(2)The production, manufacturing, distribution, or possession of a Xylazine bulk chemical for
pharmaceutical compounding by a licensed pharmacist or veterinarian.
(3)The possession of Xylazine pursuant to a valid prescription from a licensed veterinarian.
Proposed law defines "Xylazine" as Xylazine and any salt, sulfate, isomer, homologue, analogue,
or other preparation of Xylazine, and any salt, isomer, compound, derivative, precursor, homologue,
analogue, or other preparation thereof that is substantially chemically equivalent or identical to
Xylazine.
(Adds R.S. 40:989.4)
Summary of Amendments Adopted by House The House Floor Amendments to the engrossed bill:
1. Add the production, manufacturing, distribution, or possession of a Xylazine bulk
chemical for pharmaceutical compounding by licensed pharmacists or veterinarians to
the proposed law exceptions to which the proposed law crime does not apply.